Afficher la notice abrégée

HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study)

dc.rights.licenseopenen_US
dc.contributor.authorBARRE, Tangui
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMERCIE, Patrick
dc.contributor.authorMARCELLIN, Fabienne
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorESTERLE, Laure
dc.contributor.authorDUVIVIER, Claudine
dc.contributor.authorTEICHER, Elina
dc.contributor.authorBUREAU, Morgane
dc.contributor.authorCHAS, Julie
dc.contributor.authorSALMON-CERON, Dominique
dc.contributor.authorSOGNI, Philippe
dc.contributor.authorCARRIERI, Maria Patrizia
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorWITTKOP, Linda
dc.contributor.authorPROTOPOPESCU, Camelia
dc.contributor.authorGROUP, Anrs Co Hepavih Study
dc.date.accessioned2021-06-23T09:58:10Z
dc.date.available2021-06-23T09:58:10Z
dc.date.issued2021-04-27
dc.identifier.issn1573-3254 (Electronic) 1090-7165 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/79271
dc.description.abstractEnIn Western countries, tobacco smoking is highly prevalent among patients co-infected with HIV and hepatitis C virus (HCV). In the era of antiretrovirals and HCV cure, smoking-related health damages contribute greatly to morbidity and mortality in HIV-HCV co-infected patients. We used longitudinal data from the ANRS CO13 HEPAVIH cohort to identify the correlates of tobacco smoking quit attempts (TSQA) in HIV-HCV co-infected patients. TSQA were modelled using a multivariable discrete-time Cox proportional hazards model in 695 HIV-HCV co-infected tobacco smokers. HCV cure was associated with a 76% higher chance of TSQA (adjusted hazard ratio [95% confidence interval]: 1.76 [1.06-2.93], p = 0.029), and cannabis use with a 37% lower chance (0.63 [0.40-1.00], p = 0.049), independently of the mode of HIV transmission, other psychoactive substance use, and body mass index. Patients should be screened for tobacco and cannabis use at HCV treatment initiation and during follow-up. They should also be provided with comprehensive counselling and referral to addiction services. Non-smoking routes of cannabis administration should be promoted for cannabis users who wish to quit smoking tobacco.
dc.language.isoENen_US
dc.subject.enCannabis
dc.subject.enTobacco
dc.subject.enSmoking cessation
dc.subject.enHuman immunodeficiency virus
dc.subject.enHepatitis C
dc.subject.enChronic
dc.title.enHCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study)
dc.typeArticle de revueen_US
dc.identifier.doi10.1007/s10461-021-03277-xen_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed33903998en_US
bordeaux.journalAIDS and Behavioren_US
bordeaux.volume25
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamANRS CO13 HEPAVIHen_US
bordeaux.teamMORPH3Eusen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDAgence Nationale de Recherches sur le Sida et les Hépatites Viralesen_US
hal.identifierhal-03268540
hal.version1
hal.date.transferred2021-06-23T09:58:14Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=AIDS%20and%20Behavior&rft.date=2021-04-27&rft.volume=25&rft.eissn=1573-3254%20(Electronic)%201090-7165%20(Linking)&rft.issn=1573-3254%20(Electronic)%201090-7165%20(Linking)&rft.au=BARRE,%20Tangui&MERCIE,%20Patrick&MARCELLIN,%20Fabienne&ESTERLE,%20Laure&DUVIVIER,%20Claudine&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée